Bruker (BRKR) Cash from Financing Activities (2010 - 2026)

Bruker's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$204.9 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 300.2% year-over-year to -$204.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.6 million (down 101.81% YoY) and the FY2025 annual result came in at $135.1 million, down 89.01% from the prior year.
• Cash from Financing Activities was -$204.9 million for Q1 2026 at Bruker, down from -$167.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.2 billion in Q2 2024 and bottomed at -$217.4 million in Q1 2022.
• A 5-year average of $32.4 million and a median of -$51.2 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 3053.85% — and 2024, when it jumped 11321.36%.
• Bruker's Cash from Financing Activities stood at -$36.1 million in 2022, then sank by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then sank by 123.47% to -$167.6 million in 2025, then declined by 22.26% to -$204.9 million in 2026.
• Business Quant data shows BRKR's Cash from Financing Activities at -$204.9 million in Q1 2026, -$167.6 million in Q4 2025, and $258.4 million in Q3 2025.